Antares Pharma, Inc. (ATRS)

[hyperopia]

Actually H2R, that’s 2 days in a row. It reached a new 52-week high yesterday at $4, then hit another new high today at $4.20. I said back in March that I expected ATRS to hit many new 52-week highs, but I was beginning to wonder how long it would take. With the accumulation since the 3rd quarter earnings announcement, it has been difficult to keep the price down. Turning the profitability corner was a very important milestone, but it looks like the large volume was waiting to see if Tlando received approval. Breaking the $4 barrier was definitely nice to see!